Wednesday, Hall 8, 13:00-13:40

Clinical Reflections On The Use Of JAK Inhibitors And Corticosteroids: A Case Study – Insights Into Clinical Experience And Data With An Endocrinologist’s Perspective On Iatrogenic Adrenal Insufficiency

This is a promotional symposium developed and funded by Pfizer UK and intended for UK healthcare professionals, Pfizer products will be discussed.

‘Glucocorticoid-induced adrenal insufficiency – which patients might be at risk and how should they be managed?’
Dr Yasir Elhassan

Consultant Endocrinologist
Queen Elizabeth Hospital Birmingham, Birmingham, UK
Honorary Associate Professor
Institute of Metabolism and Systems Research, University of Birmingham, UK
Employed by University Hospitals Birmingham NHS FoundationTrust.
Grants/Research Support/Speaker Fees: HRA Pharma, ChromaDex

‘JAK inhibitors – efficacy, safety and real-world data’
Dr Alissa Walsh

Consultant Gastroenterologist
John Radcliffe Hospital, Oxford, UK
Disclosure: Alissa Walsh, DPhil FRCP
Employed by Oxford University Hospitals NHS Foundation Trust and the University of Oxford.
Grants/Research Support/Speaker Fees: AbbVie, Alfasigma, BMS, Buhlmann, Ferring, Galapagos, Helmsley trust, Janssen, Lilly, Pfizer, Takeda, and Norman Collisson Foundation
No stocks or share options

‘Clinical experience –
a real patient case study’

Dr Tim Ambrose

Consultant Gastroenterologist
John Radcliffe Hospital, Oxford, UK

Honoraria: Takeda
Speaker fees: Pfizer
Support for conference registration: Galapagos, Takeda

PP-UNP-GBR-9222          May 2024